Vireo Growth Inc., a multi-state, vertically-integrated cannabis operator, is pleased to announce a licensing agreement with Curio Wellness (“Curio”), a cGMP-certified, vertically-integrated cannabis company and market-leading innovator of health and wellness products. This strategic partnership will bring Curio’s celebrated Best Self Collection to the rapidly growing New York cannabis market.
Under the agreement, Vireo will have the ability to manufacture and distribute Curio’s full portfolio of products—including topicals, tablets, chews and vapes—leveraging Vireo’s existing infrastructure in New York. This capital-light growth model allows Curio to expand into one of the most promising markets in the country without the need for significant new investment, while Vireo enhances its portfolio with proven, high-demand offerings.
“We’re excited to bring Curio’s high-quality products to New York through this partnership,” said John Mazarakis, Chief Executive Officer of Vireo. “It’s a strong strategic fit that supports our focus on efficient growth and delivering premium offerings to our customers.”
Curio’s products have earned national recognition for both quality and consistency and are manufactured in compliance with Good Manufacturing Practices (GMP), ensuring they meet the stringent expectations of health-conscious cannabis consumers.
“This partnership is an exciting next step for our brand,” said Michael Bronfein, Chief Executive Officer of Curio Wellness. “Vireo has a strong track record in the New York market, and we’re confident they are the right partner to uphold the integrity of our products and deliver them to a broader audience.”
The first Curio-branded products are expected to launch in licensed New York dispensaries in Q4 2025.
